Mackenzie Financial Corp Sells 92,165 Shares of Teladoc Health, Inc. (NYSE:TDOC)

Mackenzie Financial Corp cut its holdings in Teladoc Health, Inc. (NYSE:TDOC - Free Report) by 89.5% in the 4th quarter, according to its most recent 13F filing with the SEC. The firm owned 10,788 shares of the health services provider's stock after selling 92,165 shares during the quarter. Mackenzie Financial Corp's holdings in Teladoc Health were worth $98,000 as of its most recent SEC filing.

A number of other large investors have also bought and sold shares of the business. Whipplewood Advisors LLC acquired a new stake in shares of Teladoc Health in the 4th quarter valued at about $29,000. Lindbrook Capital LLC increased its stake in Teladoc Health by 78.9% in the 4th quarter. Lindbrook Capital LLC now owns 3,654 shares of the health services provider's stock valued at $33,000 after buying an additional 1,612 shares during the last quarter. Sterling Capital Management LLC increased its stake in Teladoc Health by 776.7% in the 4th quarter. Sterling Capital Management LLC now owns 4,629 shares of the health services provider's stock valued at $42,000 after buying an additional 4,101 shares during the last quarter. Pilgrim Partners Asia Pte Ltd bought a new stake in Teladoc Health during the 4th quarter worth about $60,000. Finally, Generali Investments Management Co LLC acquired a new position in shares of Teladoc Health during the 4th quarter worth about $64,000. 76.82% of the stock is owned by institutional investors.

Insider Activity at Teladoc Health

In other news, insider Adam C. Vandervoort sold 11,011 shares of the firm's stock in a transaction that occurred on Thursday, March 20th. The shares were sold at an average price of $8.42, for a total transaction of $92,712.62. Following the transaction, the insider now directly owns 64,308 shares of the company's stock, valued at approximately $541,473.36. This trade represents a 14.62% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, insider Fernando M. Rodrigues sold 4,174 shares of the business's stock in a transaction that occurred on Tuesday, June 3rd. The shares were sold at an average price of $6.91, for a total value of $28,842.34. The disclosure for this sale can be found here. Insiders sold 29,667 shares of company stock worth $220,901 in the last ninety days. 0.58% of the stock is owned by company insiders.

Teladoc Health Stock Performance

Shares of TDOC stock traded up $0.13 during midday trading on Monday, hitting $7.40. 4,971,315 shares of the company were exchanged, compared to its average volume of 6,283,573. The firm has a market capitalization of $1.30 billion, a P/E ratio of -1.28 and a beta of 1.78. The company has a debt-to-equity ratio of 0.66, a quick ratio of 1.69 and a current ratio of 1.73. The firm's 50 day moving average price is $7.15 and its two-hundred day moving average price is $9.12. Teladoc Health, Inc. has a 52 week low of $6.35 and a 52 week high of $15.21.

Analyst Ratings Changes

A number of analysts recently issued reports on the company. Truist Financial lowered their target price on Teladoc Health from $10.00 to $9.00 and set a "hold" rating on the stock in a research report on Tuesday, May 27th. Bank of America lowered their price target on Teladoc Health from $8.00 to $7.00 and set a "neutral" rating on the stock in a research report on Wednesday, May 28th. Piper Sandler dropped their price objective on Teladoc Health from $13.00 to $12.00 and set an "overweight" rating on the stock in a research note on Thursday, February 27th. Citigroup decreased their target price on shares of Teladoc Health from $11.00 to $8.75 and set a "neutral" rating for the company in a research note on Friday, April 25th. Finally, Evercore ISI lowered their target price on shares of Teladoc Health from $8.00 to $7.00 and set an "in-line" rating on the stock in a report on Thursday, May 1st. Twelve research analysts have rated the stock with a hold rating and seven have given a buy rating to the company. According to MarketBeat.com, the stock currently has an average rating of "Hold" and an average price target of $9.60.

About Teladoc Health

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.